{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:26:05Z","timestamp":1794551165929,"version":"4.9.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10692-z","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:07:10Z","timestamp":1749629230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Curcumin and acute myeloid leukemia: a golden hope, updated insights"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-7613","authenticated-orcid":false,"given":"Hamed","family":"Soleimani Samarkhazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9755-2850","authenticated-orcid":false,"given":"Hanieh","family":"Noormohamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7769-8320","authenticated-orcid":false,"given":"Fatemeh Sadat","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8375-606X","authenticated-orcid":false,"given":"Niloofar","family":"Pilehvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4884-5218","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoosh","family":"Shanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"12","key":"10692_CR1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377","journal-title":"Blood"},{"issue":"1","key":"10692_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40364-025-00738-6","volume":"13","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H et al (2025) Unveiling the potential of CLL-1: a promising target for AML therapy. Biomark Res 13(1):28","journal-title":"Biomark Res"},{"issue":"19","key":"10692_CR3","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1182\/bloodadvances.2020002904","volume":"4","author":"MT Voso","year":"2020","unstructured":"Voso MT et al (2020) Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial. Blood Adv 4(19):4945\u20134954","journal-title":"Blood Adv"},{"issue":"1","key":"10692_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C (2023) Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol 16(1):29","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10692_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.12998\/wjcc.v11.i2.268","volume":"11","author":"YF Chen","year":"2023","unstructured":"Chen YF et al (2023) Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: an overview of Obstacles and opportunities. World J Clin Cases 11(2):268\u2013291","journal-title":"World J Clin Cases"},{"key":"10692_CR6","doi-asserted-by":"crossref","unstructured":"Tian Y et al (2023) Mechanism of multidrug resistance to chemotherapy mediated by P\u2013glycoprotein (Review). Int J Oncol, 63(5)","DOI":"10.3892\/ijo.2023.5567"},{"issue":"1","key":"10692_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12935-021-01746-w","volume":"21","author":"M Levin","year":"2021","unstructured":"Levin M et al (2021) Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance. Cancer Cell Int 21(1):53","journal-title":"Cancer Cell Int"},{"issue":"6","key":"10692_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00412-014-0482-9","volume":"123","author":"MT Esposito","year":"2014","unstructured":"Esposito MT, So CWE (2014) DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance. Chromosoma 123(6):545\u2013561","journal-title":"Chromosoma"},{"issue":"1","key":"10692_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/hon.3076","volume":"41","author":"FA Lagunas-Rangel","year":"2023","unstructured":"Lagunas-Rangel FA (2023) DNA damage accumulation and repair defects in FLT3-ITD acute myeloid leukemia: implications for clonal evolution and disease progression. Hematol Oncol 41(1):26\u201338","journal-title":"Hematol Oncol"},{"key":"10692_CR10","doi-asserted-by":"crossref","unstructured":"Sweeney C, Vyas P (2019) The graft-versus-leukemia effect in AML. Front Oncol, Volume 9\u20132019","DOI":"10.3389\/fonc.2019.01217"},{"issue":"6","key":"10692_CR11","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/jcm13061574","volume":"13","author":"S Barachini","year":"2024","unstructured":"Barachini S, Buda G, Petrini I (2024) Cardiovascular toxicity of antineoplastic treatments in hematological diseases: focus on molecular mechanisms to improve therapeutic management. J Clin Med 13(6):1574","journal-title":"J Clin Med"},{"issue":"1","key":"10692_CR12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10238-025-01588-0","volume":"25","author":"A Raoufi","year":"2025","unstructured":"Raoufi A et al (2025) Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets. Clin Experimental Med 25(1):73","journal-title":"Clin Experimental Med"},{"key":"10692_CR13","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.2147\/IJN.S251174","volume":"15","author":"S Sarli","year":"2020","unstructured":"Sarli S, Kalani MR, Moradi A (2020) A potent and safer anticancer and antibacterial Taxus-Based green synthesized silver nanoparticle. Int J Nanomed 15:3791\u20133801","journal-title":"Int J Nanomed"},{"key":"10692_CR14","doi-asserted-by":"crossref","first-page":"100444","DOI":"10.1016\/j.prmcm.2024.100444","volume":"11","author":"S Goswami","year":"2024","unstructured":"Goswami S et al (2024) Pharmacological significance of Catharanthus roseus in cancer management: A review. Pharmacol Res - Mod Chin Med 11:100444","journal-title":"Pharmacol Res - Mod Chin Med"},{"issue":"8","key":"10692_CR15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.lfs.2003.07.025","volume":"74","author":"EM Ju","year":"2004","unstructured":"Ju EM et al (2004) Antioxidant and anticancer activity of extract from Betula platyphylla var. japonica. Life Sci 74(8):1013\u20131026","journal-title":"Life Sci"},{"issue":"2","key":"10692_CR16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1134\/S0026261722602834","volume":"92","author":"THN Vu","year":"2023","unstructured":"Vu THN et al (2023) Bioprospecting endophytic Fungi isolated from Cephalotaxus Mannii Hook f. as prolific sources of antibacterial, anticancer, and antioxidant agents. Microbiology 92(2):284\u2013292","journal-title":"Microbiology"},{"issue":"2","key":"10692_CR17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12029-022-00809-z","volume":"54","author":"N Gull","year":"2023","unstructured":"Gull N et al (2023) Recent advances in anticancer activity of novel plant extracts and compounds from Curcuma longa in hepatocellular carcinoma. J Gastrointest Cancer 54(2):368\u2013390","journal-title":"J Gastrointest Cancer"},{"issue":"Suppl 2","key":"10692_CR18","first-page":"41","volume":"25","author":"GM Cragg","year":"2015","unstructured":"Cragg GM, Pezzuto JM (2015) Natural products as a vital source for the discovery of Cancer chemotherapeutic and chemopreventive agents. Med Principles Pract 25(Suppl 2):41\u201359","journal-title":"Med Principles Pract"},{"issue":"5","key":"10692_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/molecules21050559","volume":"21","author":"H Yuan","year":"2016","unstructured":"Yuan H et al (2016) The traditional medicine and modern medicine from natural products. Molecules 21(5):559","journal-title":"Molecules"},{"issue":"19","key":"10692_CR20","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.3390\/molecules26195785","volume":"26","author":"F Chueahongthong","year":"2021","unstructured":"Chueahongthong F et al (2021) Co-Treatments of edible Curcumin from turmeric rhizomes and chemotherapeutic drugs on cytotoxicity and FLT3 protein expression in leukemic stem cells. Molecules 26(19):5785","journal-title":"Molecules"},{"issue":"5","key":"10692_CR21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/ijms20051033","volume":"20","author":"MA Tomeh","year":"2019","unstructured":"Tomeh MA, Hadianamrei R, Zhao X (2019) A review of Curcumin and its derivatives as anticancer agents. Int J Mol Sci 20(5):1033","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10692_CR22","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41374-021-00640-3","volume":"101","author":"JM Liu","year":"2021","unstructured":"Liu JM et al (2021) Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the LncRNA HOTAIR\/miR-20a-5p\/WT1 axis. Lab Invest 101(10):1308\u20131317","journal-title":"Lab Invest"},{"issue":"2","key":"10692_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/antibiotics11020135","volume":"11","author":"M Uro\u0161evi\u0107","year":"2022","unstructured":"Uro\u0161evi\u0107 M et al (2022) Curcumin: biological activities and modern pharmaceutical forms. Antibiotics 11(2):135","journal-title":"Antibiotics"},{"key":"10692_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tifs.2021.02.006","volume":"110","author":"S Sabet","year":"2021","unstructured":"Sabet S et al (2021) Recent advances to improve Curcumin oral bioavailability. Trends Food Sci Technol 110:253\u2013266","journal-title":"Trends Food Sci Technol"},{"issue":"22","key":"10692_CR25","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.3390\/molecules29225321","volume":"29","author":"J Kuzminska","year":"2024","unstructured":"Kuzminska J et al (2024) Curcumin derivatives in medicinal chemistry: potential applications in Cancer treatment. Molecules 29(22):5321","journal-title":"Molecules"},{"issue":"2","key":"10692_CR26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","volume":"7","author":"A Amalraj","year":"2017","unstructured":"Amalraj A et al (2017) Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives\u2013 A review. J Traditional Complement Med 7(2):205\u2013233","journal-title":"J Traditional Complement Med"},{"issue":"15","key":"10692_CR27","doi-asserted-by":"crossref","first-page":"e202400380","DOI":"10.1002\/asia.202400380","volume":"19","author":"K Sudarshan","year":"2024","unstructured":"Sudarshan K, Yarlagadda S, Sengupta S (2024) Recent advances in the synthesis of diarylheptanoids. Chem\u2013 Asian J 19(15):e202400380","journal-title":"Chem\u2013 Asian J"},{"key":"10692_CR28","doi-asserted-by":"crossref","first-page":"115971","DOI":"10.1016\/j.bmc.2020.115971","volume":"31","author":"C Vanucci-Bacqu\u00e9","year":"2021","unstructured":"Vanucci-Bacqu\u00e9 C, Bedos-Belval F (2021) Anti-inflammatory activity of naturally occuring diarylheptanoids\u2013 A review. Bioorg Med Chem 31:115971","journal-title":"Bioorg Med Chem"},{"issue":"14","key":"10692_CR29","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1002\/jsfa.11372","volume":"101","author":"ME Abd El-Hack","year":"2021","unstructured":"Abd El-Hack ME et al (2021) Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric 101(14):5747\u20135762","journal-title":"J Sci Food Agric"},{"issue":"16","key":"10692_CR30","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.18632\/oncotarget.28031","volume":"12","author":"A Chota","year":"2021","unstructured":"Chota A, George BP, Abrahamse H (2021) Interactions of multidomain pro-apoptotic and anti-apoptotic proteins in cancer cell death. Oncotarget 12(16):1615\u20131626","journal-title":"Oncotarget"},{"key":"10692_CR31","doi-asserted-by":"crossref","unstructured":"Kah G, Chandran R, Abrahamse H (2023) Curcumin a natural phenol and its therapeutic role in cancer and photodynamic therapy: A review. Pharmaceutics, 15(2)","DOI":"10.3390\/pharmaceutics15020639"},{"issue":"4","key":"10692_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2025.8965","volume":"45","author":"H Zhou","year":"2021","unstructured":"Zhou H et al (2021) Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT. Oncol Rep 45(4):1\u20131","journal-title":"Oncol Rep"},{"issue":"1","key":"10692_CR33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10495-013-0927-2","volume":"19","author":"AA Ashour","year":"2014","unstructured":"Ashour AA et al (2014) Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells. Apoptosis 19(1):241\u2013258","journal-title":"Apoptosis"},{"key":"10692_CR34","doi-asserted-by":"crossref","unstructured":"Gachpazan M Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis, in Studies on Biomarkers and New Targets in Aging Research in Iran: Focus on Turmeric and Curcumin, Guest PC et al (2021) Editor. Springer International Publishing: Cham. pp. 41\u201353","DOI":"10.1007\/978-3-030-56153-6_3"},{"issue":"4","key":"10692_CR35","doi-asserted-by":"crossref","first-page":"e4030","DOI":"10.1002\/cbf.4030","volume":"42","author":"MY Zamanian","year":"2024","unstructured":"Zamanian MY et al (2024) NF-\u03baB pathway as a molecular target for Curcumin in diabetes mellitus treatment: focusing on oxidative stress and inflammation. Cell Biochem Funct 42(4):e4030","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10692_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13058-024-01868-9","volume":"26","author":"N Bahadar","year":"2024","unstructured":"Bahadar N et al (2024) Epigallocatechin gallate and Curcumin inhibit Bcl-2: a pharmacophore and Docking based approach against cancer. Breast Cancer Res 26(1):114","journal-title":"Breast Cancer Res"},{"key":"10692_CR37","doi-asserted-by":"crossref","unstructured":"Singh S et al (2022) Curcumin, a potential initiator of apoptosis via direct interactions with Bcl-xL and bid. Proteins: structure, function, and bioinformatics. 90(2):455\u2013464","DOI":"10.1002\/prot.26238"},{"issue":"5","key":"10692_CR38","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1007\/s10876-023-02404-z","volume":"34","author":"S Amirsaadat","year":"2023","unstructured":"Amirsaadat S et al (2023) Potential Anti-Proliferative effect of Nano-formulated Curcumin through modulating Micro RNA- 132, Cyclin D1, and hTERT genes expression in breast Cancer cell lines. J Cluster Sci 34(5):2537\u20132546","journal-title":"J Cluster Sci"},{"issue":"2","key":"10692_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/0115748928261490231124055059","volume":"20","author":"J Su","year":"2025","unstructured":"Su J et al (2025) Curcumin inhibits the growth of hepatocellular carcinoma via the MARCH1-mediated modulation of JAK2\/STAT3 signaling. Recent Pat Anticancer Drug Discov 20(2):145\u2013157","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"7","key":"10692_CR40","doi-asserted-by":"crossref","first-page":"e4119","DOI":"10.1002\/cbf.4119","volume":"42","author":"BP Pereira","year":"2024","unstructured":"Pereira BP et al (2024) Curcumin prevents renal damage of l-NAME induced hypertension in by reducing MMP-2 and MMP-9. Cell Biochem Funct 42(7):e4119","journal-title":"Cell Biochem Funct"},{"key":"10692_CR41","doi-asserted-by":"crossref","first-page":"105743","DOI":"10.1016\/j.ejps.2021.105743","volume":"160","author":"M Mohan","year":"2021","unstructured":"Mohan M et al (2021) Symmetrical and un-symmetrical Curcumin analogues as selective COX-1 and COX-2 inhibitor. Eur J Pharm Sci 160:105743","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10692_CR42","first-page":"3656419","volume":"2020","author":"NE Rainey","year":"2020","unstructured":"Rainey NE, Moustapha A, Petit PX (2020) Curcumin, a multifaceted hormetic agent, mediates an intricate crosstalk between mitochondrial turnover, autophagy, and apoptosis. Oxidative Med Cell Longev 2020(1):3656419","journal-title":"Oxidative Med Cell Longev"},{"key":"10692_CR43","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fnins.2019.01223","volume":"13","author":"Y Gao","year":"2019","unstructured":"Gao Y et al (2019) Curcumin mitigates neuro-inflammation by modulating microglia polarization through inhibiting TLR4 axis signaling pathway following experimental subarachnoid hemorrhage. Front NeuroSci 13:1223","journal-title":"Front NeuroSci"},{"issue":"12","key":"10692_CR44","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1039\/C9FO02159K","volume":"10","author":"Q Li","year":"2019","unstructured":"Li Q et al (2019) Curcumin inhibits cigarette smoke-induced inflammation via modulating the PPAR\u03b3-NF-\u03baB signaling pathway. Food Funct 10(12):7983\u20137994","journal-title":"Food Funct"},{"issue":"1","key":"10692_CR45","first-page":"4927430","volume":"2019","author":"T Zhu","year":"2019","unstructured":"Zhu T et al (2019) Curcumin attenuates asthmatic airway inflammation and mucus hypersecretion involving a PPAR\u03b3-dependent NF\u2010\u03baB signaling pathway in vivo and in vitro. Mediat Inflamm 2019(1):4927430","journal-title":"Mediat Inflamm"},{"issue":"8","key":"10692_CR46","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ptr.6642","volume":"34","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M et al (2020) Potential therapeutic effects of Curcumin mediated by JAK\/STAT signaling pathway: a review. Phytother Res 34(8):1745\u20131760","journal-title":"Phytother Res"},{"key":"10692_CR47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10787-019-00607-3","volume":"27","author":"KR Kahkhaie","year":"2019","unstructured":"Kahkhaie KR et al (2019) Curcumin: a modulator of inflammatory signaling pathways in the immune system. Inflammopharmacology 27:885\u2013900","journal-title":"Inflammopharmacology"},{"key":"10692_CR48","doi-asserted-by":"crossref","first-page":"104921","DOI":"10.1016\/j.phrs.2020.104921","volume":"159","author":"S Hasanzadeh","year":"2020","unstructured":"Hasanzadeh S et al (2020) Curcumin: an inflammasome silencer. Pharmacol Res 159:104921","journal-title":"Pharmacol Res"},{"key":"10692_CR49","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10571-018-0616-3","volume":"38","author":"G Chen","year":"2018","unstructured":"Chen G et al (2018) Curcumin attenuates gp120-induced microglial inflammation by inhibiting autophagy via the PI3K pathway. Cell Mol Neurobiol 38:1465\u20131477","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10692_CR50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.intimp.2014.01.024","volume":"20","author":"Y Fu","year":"2014","unstructured":"Fu Y et al (2014) Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-\u03baB signaling pathway in lipopolysaccharide-induced mastitis in mice. Int Immunopharmacol 20(1):54\u201358","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10692_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2020.11672","volume":"23","author":"C Wei","year":"2021","unstructured":"Wei C et al (2021) Curcumin ameliorates DSS\u2013induced colitis in mice by regulating the Treg\/Th17 signaling pathway. Mol Med Rep 23(1):1\u20131","journal-title":"Mol Med Rep"},{"issue":"11","key":"10692_CR52","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/antiox9111092","volume":"9","author":"K Jakubczyk","year":"2020","unstructured":"Jakubczyk K et al (2020) Antioxidant potential of Curcumin\u2014A Meta-Analysis of randomized clinical trials. Antioxidants 9(11):1092","journal-title":"Antioxidants"},{"issue":"5","key":"10692_CR53","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00213-023-06357-z","volume":"240","author":"D Liao","year":"2023","unstructured":"Liao D et al (2023) Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways. Psychopharmacology 240(5):1179\u20131190","journal-title":"Psychopharmacology"},{"issue":"4","key":"10692_CR54","first-page":"263","volume":"4","author":"AM McDonnell","year":"2013","unstructured":"McDonnell AM, Dang CH (2013) Basic review of the cytochrome p450 system. J Adv Pract Oncol 4(4):263\u2013268","journal-title":"J Adv Pract Oncol"},{"issue":"18","key":"10692_CR55","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.3390\/ijms20184606","volume":"20","author":"PR Casta\u00f1o","year":"2019","unstructured":"Casta\u00f1o PR, Parween S, Pandey AV (2019) Bioactivity of Curcumin on the cytochrome P450 enzymes of the steroidogenic pathway. Int J Mol Sci 20(18):4606","journal-title":"Int J Mol Sci"},{"issue":"34","key":"10692_CR56","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.2174\/0929867328666210329123449","volume":"28","author":"H Mashayekhi-Sardoo","year":"2021","unstructured":"Mashayekhi-Sardoo H et al (2021) Impact of Curcumin on microsomal enzyme activities: drug interaction and chemopreventive studies. Curr Med Chem 28(34):7122\u20137140","journal-title":"Curr Med Chem"},{"key":"10692_CR57","doi-asserted-by":"crossref","unstructured":"Yu C, Yang B, Najafi M (2021) Targeting of cancer cell death mechanisms by curcumin: implications to cancer therapy, vol 129. Basic & clinical pharmacology & toxicology, pp 397\u2013415. 6","DOI":"10.1111\/bcpt.13648"},{"issue":"6","key":"10692_CR58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/bcpt.13648","volume":"129","author":"C Yu","year":"2021","unstructured":"Yu C, Yang B, Najafi M (2021) Targeting of cancer cell death mechanisms by curcumin: implications to cancer therapy. Basic Clin Pharmacol Toxicol 129(6):397\u2013415","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10692_CR59","first-page":"100422","volume":"28","author":"FH Al-Ostoot","year":"2021","unstructured":"Al-Ostoot FH et al (2021) Tumor angiogenesis: current challenges and therapeutic opportunities. Cancer Treat Res Commun 28:100422","journal-title":"Cancer Treat Res Commun"},{"issue":"23","key":"10692_CR60","doi-asserted-by":"crossref","first-page":"19469","DOI":"10.18632\/oncotarget.3625","volume":"6","author":"Z Fu","year":"2015","unstructured":"Fu Z et al (2015) Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget 6(23):19469\u201319482","journal-title":"Oncotarget"},{"key":"10692_CR61","doi-asserted-by":"crossref","unstructured":"Younes M et al (2022) The synergistic effects of Curcumin and chemotherapeutic drugs in inhibiting metastatic, invasive and proliferative pathways. Plants (Basel), 11(16)","DOI":"10.3390\/plants11162137"},{"key":"10692_CR62","doi-asserted-by":"crossref","unstructured":"Hsiao PC et al (2020) The Curcumin analogue, EF-24, triggers p38 MAPK-Mediated apoptotic cell death via inducing PP2A-Modulated ERK deactivation in human acute myeloid leukemia cells. Cancers (Basel), 12(8)","DOI":"10.3390\/cancers12082163"},{"issue":"2","key":"10692_CR63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00280-021-04385-0","volume":"89","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota. Cancer Chemother Pharmacol 89(2):243\u2013253","journal-title":"Cancer Chemother Pharmacol"},{"key":"10692_CR64","doi-asserted-by":"crossref","unstructured":"Papie\u017c MA et al (2016) Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species. Drug design, development and therapy,: pp. 557\u2013570","DOI":"10.2147\/DDDT.S92687"},{"key":"10692_CR65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1479-5876-9-71","volume":"9","author":"J Rao","year":"2011","unstructured":"Rao J et al (2011) Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34\u2009+\u2009acute myeloid leukemia cell lines and primary sorted CD34\u2009+\u2009acute myeloid leukemia cells. J Transl Med 9:71","journal-title":"J Transl Med"},{"key":"10692_CR66","doi-asserted-by":"crossref","unstructured":"Nirachonkul W et al (2021) CD123-Targeted Nano-Curcumin molecule enhances cytotoxic efficacy in leukemic stem cells. Nanomaterials (Basel), 11(11)","DOI":"10.3390\/nano11112974"},{"issue":"5","key":"10692_CR67","first-page":"6777","volume":"15","author":"M Mart\u00ednez-Castillo","year":"2018","unstructured":"Mart\u00ednez-Castillo M et al (2018) Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells. Oncol Lett 15(5):6777\u20136783","journal-title":"Oncol Lett"},{"issue":"42","key":"10692_CR68","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","volume":"270","author":"S Singh","year":"1995","unstructured":"Singh S, Aggarwal BB (1995) Activation of transcription factor NF-\u03baB is suppressed by Curcumin (Diferuloylmethane) (\u2217). J Biol Chem 270(42):24995\u201325000","journal-title":"J Biol Chem"},{"issue":"6","key":"10692_CR69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tips.2009.03.004","volume":"30","author":"G Sethi","year":"2009","unstructured":"Sethi G, Tergaonkar V (2009) Potential Pharmacological control of the NF-\u03baB pathway. Trends Pharmacol Sci 30(6):313\u2013321","journal-title":"Trends Pharmacol Sci"},{"key":"10692_CR70","doi-asserted-by":"crossref","unstructured":"Trombetti S et al (2021) Oxidative stress and ROS-Mediated signaling in leukemia: novel promising perspectives to eradicate chemoresistant cells in myeloid leukemia. Int J Mol Sci, 22(5)","DOI":"10.3390\/ijms22052470"},{"key":"10692_CR71","doi-asserted-by":"crossref","unstructured":"Gruszka AM, Valli D, Alcalay M (2019) Wnt signalling in acute myeloid leukaemia. Cells, 8(11)","DOI":"10.3390\/cells8111403"},{"key":"10692_CR72","doi-asserted-by":"crossref","first-page":"1409210","DOI":"10.3389\/fphar.2024.1409210","volume":"15","author":"M Chomczyk","year":"2024","unstructured":"Chomczyk M et al (2024) Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment. Front Pharmacol 15:1409210","journal-title":"Front Pharmacol"},{"issue":"1","key":"10692_CR73","doi-asserted-by":"crossref","first-page":"20220618","DOI":"10.1515\/biol-2022-0618","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang X et al (2023) Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3\/VEGF\/HIF-1\u03b1 signaling. Open Life Sci 18(1):20220618","journal-title":"Open Life Sci"},{"key":"10692_CR74","doi-asserted-by":"crossref","first-page":"116034","DOI":"10.1016\/j.biopha.2023.116034","volume":"170","author":"MR Islam","year":"2024","unstructured":"Islam MR et al (2024) Targeted therapies of Curcumin focus on its therapeutic benefits in cancers and human health: molecular signaling pathway-based approaches and future perspectives. Biomed Pharmacother 170:116034","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10692_CR75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44\u201384","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"10692_CR76","first-page":"3055","volume":"18","author":"M Salemi","year":"2017","unstructured":"Salemi M et al (2017) Anti-Vascular endothelial growth factor targeting by Curcumin and thalidomide in acute myeloid leukemia cells. Asian Pac J Cancer Prev 18(11):3055\u20133061","journal-title":"Asian Pac J Cancer Prev"},{"key":"10692_CR77","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fimmu.2018.00745","volume":"9","author":"A Vall\u00e9e","year":"2018","unstructured":"Vall\u00e9e A, Lecarpentier Y (2018) Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT\/\u03b2-catenin pathway in chronic inflammation and oxidative stress during carcinogenesis. Front Immunol 9:745","journal-title":"Front Immunol"},{"issue":"9","key":"10692_CR78","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41388-018-0526-3","volume":"38","author":"PSY Chong","year":"2019","unstructured":"Chong PSY et al (2019) Non-canonical activation of \u03b2-catenin by PRL-3 phosphatase in acute myeloid leukemia. Oncogene 38(9):1508\u20131519","journal-title":"Oncogene"},{"key":"10692_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1320-y","volume":"38","author":"A Vall\u00e9e","year":"2019","unstructured":"Vall\u00e9e A, Lecarpentier Y, Vall\u00e9e J-N (2019) Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT\/\u03b2-catenin pathway. J Experimental Clin Cancer Res 38:1\u201316","journal-title":"J Experimental Clin Cancer Res"},{"key":"10692_CR80","doi-asserted-by":"crossref","unstructured":"Lilly MB et al (2004) Expression of Cyclooxygenase-2 (COX-2) in human leukemias and hematopoietic cells. American Society of Hematology","DOI":"10.1182\/blood.V104.11.4336.4336"},{"issue":"8","key":"10692_CR81","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/cancers16081554","volume":"16","author":"V Zoi","year":"2024","unstructured":"Zoi V et al (2024) The role of Curcumin in cancer: A focus on the PI3K\/Akt pathway. Cancers 16(8):1554","journal-title":"Cancers"},{"key":"10692_CR82","doi-asserted-by":"crossref","unstructured":"Wu JC et al (2011) Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K\/Akt-mTOR and MAPK signaling pathways in human leukemia HL\u201060 cells. Molecular nutrition & food research,55(11):1646\u20131654.","DOI":"10.1002\/mnfr.201100454"},{"issue":"9","key":"10692_CR83","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JSC Arthur","year":"2013","unstructured":"Arthur JSC, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13(9):679\u2013692","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10692_CR84","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/biomedicines9091086","volume":"9","author":"V Zoi","year":"2021","unstructured":"Zoi V et al (2021) The role of Curcumin in cancer treatment. Biomedicines 9(9):1086","journal-title":"Biomedicines"},{"issue":"2","key":"10692_CR85","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/ph17020164","volume":"17","author":"V Bu\u010devi\u0107 Popovi\u0107","year":"2024","unstructured":"Bu\u010devi\u0107 Popovi\u0107 V et al (2024) Bioavailability of oral Curcumin in systematic reviews: A methodological study. Pharmaceuticals 17(2):164","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10692_CR86","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1021\/acsomega.2c07326","volume":"8","author":"M Hegde","year":"2023","unstructured":"Hegde M et al (2023) Curcumin formulations for better bioavailability: what we learned from clinical trials thus far? ACS Omega 8(12):10713\u201310746","journal-title":"ACS Omega"},{"issue":"3","key":"10692_CR87","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/antiox13030331","volume":"13","author":"C Bertoncini-Silva","year":"2024","unstructured":"Bertoncini-Silva C et al (2024) Enhancing the bioavailability and bioactivity of Curcumin for disease prevention and treatment. Antioxidants 13(3):331","journal-title":"Antioxidants"},{"issue":"14","key":"10692_CR88","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/molecules24142527","volume":"24","author":"BL Tan","year":"2019","unstructured":"Tan BL, Norhaizan ME (2019) Curcumin combination chemotherapy: the implication and efficacy in cancer. Molecules 24(14):2527","journal-title":"Molecules"},{"issue":"16","key":"10692_CR89","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.3390\/molecules27165236","volume":"27","author":"S Hafez Ghoran","year":"2022","unstructured":"Hafez Ghoran S et al (2022) Curcumin-based nanoformulations: A promising adjuvant towards cancer treatment. Molecules 27(16):5236","journal-title":"Molecules"},{"issue":"5","key":"10692_CR90","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.3390\/molecules17055972","volume":"17","author":"Y Chen","year":"2012","unstructured":"Chen Y et al (2012) Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17(5):5972\u20135987","journal-title":"Molecules"},{"issue":"20","key":"10692_CR91","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1021\/acsami.7b02863","volume":"9","author":"D Sun","year":"2017","unstructured":"Sun D et al (2017) Novel Curcumin liposome modified with hyaluronan targeting CD44 plays an Anti-Leukemic role in acute myeloid leukemia in vitro and in vivo. ACS Appl Mater Interfaces 9(20):16857\u201316868","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"10692_CR92","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1038\/srep10322","volume":"5","author":"X Yang","year":"2015","unstructured":"Yang X et al (2015) Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo. Sci Rep 5(1):10322","journal-title":"Sci Rep"},{"key":"10692_CR93","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpb.2016.12.032","volume":"114","author":"S Tima","year":"2017","unstructured":"Tima S et al (2017) Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. Eur J Pharm Biopharm 114:57\u201368","journal-title":"Eur J Pharm Biopharm"},{"key":"10692_CR94","doi-asserted-by":"crossref","unstructured":"Panda AK et al (2017) New insights into therapeutic activity and anticancer properties of Curcumin. J Experimental Pharmacol,: p. 31\u201345","DOI":"10.2147\/JEP.S70568"},{"issue":"11","key":"10692_CR95","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3390\/nano11112974","volume":"11","author":"W Nirachonkul","year":"2021","unstructured":"Nirachonkul W et al (2021) CD123-targeted nano-curcumin molecule enhances cytotoxic efficacy in leukemic stem cells. Nanomaterials 11(11):2974","journal-title":"Nanomaterials"},{"issue":"12","key":"10692_CR96","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1021\/acsomega.0c06314","volume":"6","author":"SS Hettiarachchi","year":"2021","unstructured":"Hettiarachchi SS et al (2021) Synthesis of Curcumin nanoparticles from Raw turmeric rhizome. ACS Omega 6(12):8246\u20138252","journal-title":"ACS Omega"},{"key":"10692_CR97","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00280-014-2447-3","volume":"73","author":"JM Reid","year":"2014","unstructured":"Reid JM et al (2014) Mouse pharmacokinetics and metabolism of the Curcumin analog, 4-piperidinone, 3, 5-bis [(2-fluorophenyl) methylene]-acetate (3E, 5E)(EF-24; NSC 716993). Cancer Chemother Pharmacol 73:1137\u20131146","journal-title":"Cancer Chemother Pharmacol"},{"key":"10692_CR98","doi-asserted-by":"crossref","first-page":"114351","DOI":"10.1016\/j.biopha.2023.114351","volume":"160","author":"H Goel","year":"2023","unstructured":"Goel H et al (2023) Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia. Biomed Pharmacother 160:114351","journal-title":"Biomed Pharmacother"},{"key":"10692_CR99","doi-asserted-by":"crossref","first-page":"113072","DOI":"10.1016\/j.ejmech.2020.113072","volume":"210","author":"MS Hosseini-Zare","year":"2021","unstructured":"Hosseini-Zare MS et al (2021) Synergistic effects of Curcumin and its analogs with other bioactive compounds: A comprehensive review. Eur J Med Chem 210:113072","journal-title":"Eur J Med Chem"},{"key":"10692_CR100","doi-asserted-by":"crossref","unstructured":"Bordoloi D, Kunnumakkara AB (2018) The potential of curcumin: a multitargeting agent in cancer cell chemosensitization, in role of nutraceuticals in cancer chemosensitization. Elsevier, pp 31\u201360","DOI":"10.1016\/B978-0-12-812373-7.00002-4"},{"issue":"1","key":"10692_CR101","doi-asserted-by":"crossref","first-page":"17724","DOI":"10.1038\/s41598-017-16436-9","volume":"7","author":"X Chen","year":"2017","unstructured":"Chen X et al (2017) Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression. Sci Rep 7(1):17724","journal-title":"Sci Rep"},{"issue":"1","key":"10692_CR102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.110.168344","volume":"335","author":"Y Sanchez","year":"2010","unstructured":"Sanchez Y et al (2010) Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and Lonidamine in human myeloid leukemia cell lines. J Pharmacol Exp Ther 335(1):114\u2013123","journal-title":"J Pharmacol Exp Ther"},{"key":"10692_CR103","unstructured":"Fan J-X et al (2014) Synergistic killing effect of arsenic trioxide combined with Curcumin on KG1a cells. Zhongguo Shi Yan Xue ye Xue Za Zhi. 22(5):1267\u20131272"},{"issue":"2","key":"10692_CR104","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejps.2010.06.011","volume":"41","author":"J Chen","year":"2010","unstructured":"Chen J et al (2010) Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells. Eur J Pharm Sci 41(2):210\u2013218","journal-title":"Eur J Pharm Sci"},{"key":"10692_CR105","doi-asserted-by":"crossref","unstructured":"Mohammadi Kian M et al (2020) Curcumin combined with thalidomide reduces expression of STAT3 and Bcl-xL, leading to apoptosis in acute myeloid leukemia cell lines. Drug Des Devel Ther,: p. 185\u20131941177","DOI":"10.2147\/DDDT.S228610"},{"key":"10692_CR106","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s43440-020-00073-7","volume":"72","author":"S Surapally","year":"2020","unstructured":"Surapally S, Jayaprakasam M, Verma RS (2020) Curcumin augments therapeutic efficacy of TRAIL-based immunotoxins in leukemia. Pharmacol Rep 72:1032\u20131046","journal-title":"Pharmacol Rep"},{"issue":"7","key":"10692_CR107","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.3390\/ijms24076621","volume":"24","author":"S Servida","year":"2023","unstructured":"Servida S et al (2023) Overview of Curcumin and Piperine effects on glucose metabolism: the case of an Insulinoma patient\u2019s loss of consciousness. Int J Mol Sci 24(7):6621","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10692_CR108","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3109\/10428194.2013.776167","volume":"54","author":"ME El-Houseini","year":"2013","unstructured":"El-Houseini ME et al (2013) Potential role of Curcumin and taurine combination therapy on human myeloid leukemic cells propagated in vitro. Leuk Lymphoma 54(10):2281\u20132287","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10692_CR109","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/01635581003693082","volume":"62","author":"S Pesakhov","year":"2010","unstructured":"Pesakhov S et al (2010) Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and Silibinin on proliferation and apoptosis in acute myeloid leukemia cells. Nutr Cancer 62(6):811\u2013824","journal-title":"Nutr Cancer"},{"issue":"1","key":"10692_CR110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.110.168344","volume":"335","author":"Y S\u00e1nchez","year":"2010","unstructured":"S\u00e1nchez Y et al (2010) Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and Lonidamine in human myeloid leukemia cell lines. J Pharmacol Exp Ther 335(1):114\u2013123","journal-title":"J Pharmacol Exp Ther"},{"key":"10692_CR111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DDDT.S228610","volume":"14","author":"M Mohammadi Kian","year":"2020","unstructured":"Mohammadi Kian M et al (2020) Curcumin combined with thalidomide reduces expression of STAT3 and Bcl-xL, leading to apoptosis in acute myeloid leukemia cell lines. Drug Des Devel Ther 14:185\u2013194","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"10692_CR112","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s43440-020-00073-7","volume":"72","author":"S Surapally","year":"2020","unstructured":"Surapally S, Jayaprakasam M, Verma RS (2020) Curcumin augments therapeutic efficacy of TRAIL-based immunotoxins in leukemia. Pharmacol Rep 72(4):1032\u20131046","journal-title":"Pharmacol Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10692-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:27:44Z","timestamp":1766852864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10692"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10692-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"583"}}